Follow TNGB

Pfizer Delays Heart Risk Study for Young Vaccine Recipients to 2030
Pfizer has postponed a critical study examining heart inflammation risks in individuals under 21 who received…
Jun 28, 2025

Pfizer has postponed a critical study examining heart inflammation risks in individuals under 21 who received…
Full Story The U.S. Food and Drug Administration approved Novavax’s COVID-19 vaccine on Friday with added…